BIO-TECHNE Corp 4

Shane Bohnen, SVP and General Counsel of Bio‑Techne Corp, exercised 448 stock options at $47.60 and had 344 shares withheld/disposed for taxes on July 23, 2026, resulting in 7,353 common shares held directly.

On July 23, 2026, Bio-Techne Corp SVP and General Counsel Shane Bohnen exercised 448 stock options at an exercise price of $47.60 per share (coded transaction “M”), acquiring an equivalent number of common shares valued at approximately $21,325 using the exercise price as a proxy. On the same date, 344 shares of common stock were withheld or disposed of at $71.77 per share in a transaction coded “F,” a typical tax-withholding sale associated with equity vesting, for an implied value of about $24,699. After these transactions, Bohnen directly owned 7,353 shares of Bio‑Techne common stock. The filing also lists Bohnen’s remaining option and equity award inventory across multiple strike prices and future vesting dates, but these entries are informational about outstanding derivative and RSU/PSU positions rather than new grants or open‑market trades on the filing date.

Filing Facts

CIK

842023

Ticker

TECH

Form

4

Source Type

fda

Accession

0000914190-26-000104

Alert Tier

5